Identifying Antistreptokinase Antibodies: Economic Impact of Point-of-Care Testing in the Setting of Prior Myocardial Infarction

Author： Massel D.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.22, Iss.12, 2002-01, pp. : 837-848

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Point-of-Care Testing in Diabetes Care

By  

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 2, 2011-02 ,pp. : 178-184

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical interest of point-of-care pharmacogenomic testing: clopidogrel behind warfarin

By Shahabi Payman   Siest Gérard   Visvikis-Siest Sophie  

Pharmacogenomics, Vol. 13, Iss. 11, 2012-08 ,pp. : 1215-1218

Future Medicine

Access to resources Recommend Favorite

Exploring Point‐of‐Care Testing of Capillary Blood in Warfarin Management

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 38, Iss. 4, 2008-12 ,pp. : 300-304

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of a new hemoglobin A1c analyzer for point‐of‐care testing

By  

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 32, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Calcium Antagonists in the Post-Myocardial Infarction Setting

By Bertolet B.D.  

Drugs & Aging, Vol. 15, Iss. 6, 1999-12 ,pp. : 461-470

Adis International

Access to resources Recommend Favorite